“…Borneol ( Figure 1 ), Chinese materia medica monomer (molecular weight 154.24), is extracted from Dryobalanops aromatica Gaertn f. and Blumea balsamifera DC , and is widely used for the treatment of cardiovascular and cerebrovascular diseases in China. Previous studies showed that borneol was able to improve the permeability of BBB by a physiological process, enhance penetration and accumulation of some drugs into the brain such as tetramethylpyrazine phosphate, gastrodin, puerarin, geniposide, kaempferol and nimodipine, and increase the brain bioavailability of these drugs [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 ]. The mechanisms of borneol opened BBB focused on loosening the endothelial tight junctions, increasing the number and volume of pinocytosis, and decreasing the mdr1a and mdr1b expression in hippocampus and hypothalamus [ 20 , 21 , 22 ].…”